# EDGAR Filing Document

**Accession Number:** 0001051219
**File Stem:** 0001162044-25-000785
**Filing Date:** 2025-8
**Character Count:** 85545
**Document Hash:** 759e89a690d6d92d047cc07afd431ceb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001162044-25-000785.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001162044-25-000785

**CONFORMED SUBMISSION TYPE**: N-CSRS

**PUBLIC DOCUMENT COUNT**: 23

**CONFORMED PERIOD OF REPORT**: 20250531

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**EFFECTIVENESS DATE**: 20250801

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TANAKA FUNDS INC
- **CENTRAL INDEX KEY:** 0001051219

**ORGANIZATION NAME:**
- **EIN:** 541891278
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** N-CSRS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08683
- **FILM NUMBER:** 251174316

**BUSINESS ADDRESS:**
- **STREET 1:** 60 EAST 42ND STREET
- **STREET 2:** SUITE 4000
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10165
- **BUSINESS PHONE:** 2124903380

**MAIL ADDRESS:**
- **STREET 1:** 60 EAST 42ND STREET
- **STREET 2:** SUITE 4000
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10165

## Series and Classes Contracts Data

### TANAKA Growth Fund (Series ID: S000004755)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000012945 | Class R      | TGFRX           |

?xml version='1.0' encoding='ASCII'? FORM N-CSRS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT

INVESTMENT COMPANIES

Investment Company Act file number <u>811-08683</u>

<u>TANAKA Funds, Inc.</u>

(Exact name of registrant as specified in charter)

<u>60 East 42<sup>nd</sup> Street, Suite 4000, New York, NY 10165</u>

(Address of principal executive offices) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Zip code)

Greg Getts

Mutual Shareholder Services

8000 Town Centre Drive, Suite 400

Broadview Heights <u>Ohio 44147</u>

(Name and address of agent for service)

Registrant's telephone number, including area code: <u>877-482-6252</u>

Date of fiscal year end: <u>November 30</u>

Date of reporting period: <u>May 31, 2025</u>

Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. S 3507.

**Item 1. Reports to Stockholders.**

![](image_001.gif)

SEMI-ANNUAL SHAREHOLDER REPORT

**May 31, 2025**

TANAKA GROWTH FUND

***TGFRX***

**<u>ADDITIONAL INFORMATION</u>**

This semi-annual shareholder report contains important information about the Tanaka Growth Fund - TGFRX (the "Fund") for the period December 1, 2024 to May 31, 2025.

You can find additional information about the fund at https://tanaka.com/tanaka-growth-fund. You can also request this information by contacting us at 1-877-4-TANAKA.

**<u>expense Information</u>**

**What were the Fund costs for the past six months?**

(based on a hypothetical $10,000 investment)

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Fund Name | &nbsp;&nbsp;**Costs of a $10,000 investment** | &nbsp;&nbsp;**Costs paid as a percentage of a $10,000 investment\*** |
| &nbsp;&nbsp;Tanaka Growth Fund | &nbsp;&nbsp;$100.00 | &nbsp;&nbsp;2.04% |

---

\*Annualized

**<u>managment's discussion of fund performance</u>**

The TANAKA Growth Fund was up 2.8% in its fiscal 2<sup>nd</sup> Quarter ending May 31<sup>st</sup> compared to a gain of 0.7% for the Wilshire 2500 Growth index and a decline of 0.4% for the S&P 500.

A diverse mix of our stock-picks contributed to the Fund's performance, spanning from Small Cap to Mega Cap, Growth to Defensive/Value, and across industries, highlighting the benefits of diversification in an uncertain and rapidly evolving macro environment. Our top performers included a specialty pharma company, the leading Artificial Intelligence (AI) chipmaker, a gold miner, uranium developers and producers, a warehouse automation company, and a defensive consumer staples holding. Partially offsetting gains in the quarter were declines in our short S&P 500 ETF that we purchased as a hedge, two Tech holdings that faced near-term headwinds, and Financials that lagged due to macroeconomic uncertainty but have since recovered in recent weeks.

While the magnitude of stock market gains over the last few months may be harder to come by in the 2nd half of the year given elevated valuations and risks to economic growth and inflation, we still see ample investment opportunities within equities and believe actively picking stocks with idiosyncratic growth drivers will be key to outperforming the broader market going forward. We continue to lean into our strategy of investing in stocks that are more dependent on company-specific growth initiatives and have recently invested in four new Platform Growth companies in the critical mineral, electric battery, and biotech industries that we believe can keep the portfolio fresh and provide growth in both the near- and long-term. While most stocks are not immune to periods of market or economic volatility, we are encouraged that our positions underpinned by secular growth trends like AI, Clean Energy, and Aging Demographics as well as those aligned with the current administration's policy initiatives like critical minerals and energy security provide growth opportunities that are less dependent on a strong economy, in our view.

**<u>Performance graph</u>**

**TOTAL RETURNS FOR THE FISCAL PERIOD ENDED MAY 31, 2025**

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **<u>FUND/INDEX</u>** | &nbsp;&nbsp;**ONE YEAR** | &nbsp;&nbsp;**FIVE YEAR** | &nbsp;&nbsp;**TEN YEAR** | &nbsp;&nbsp;**VALUE** |
| &nbsp;&nbsp;Tanaka Growth Fund | &nbsp;&nbsp;10.19% | &nbsp;&nbsp;22.70% | &nbsp;&nbsp;8.99% | &nbsp;&nbsp;23663 |
| &nbsp;&nbsp;Wilshire 2500 Growth Fund | &nbsp;&nbsp;14.98% | &nbsp;&nbsp;17.55% | &nbsp;&nbsp;14.78% | &nbsp;&nbsp;39685 |

---

**Comparison of the Growth of a $10,000 Investment in the TANAKA Growth Fund, Class R and the Wilshire 2500 Growth Index**

![](image_002.gif)

Past performance is not a good predictor of future performance. The returns shown do not reflect taxes that a shareholder would pay on Fund distributions or on the redemption of Fund shares. Updated performance data current to the most recent month-end can be obtained at https://tanaka.com/tanaka-growth-fund or by calling 1-877-4-TANAKA.

**<u>Fund statistics</u>**

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;PORTFOLIO | &nbsp;&nbsp;PORTFOLIO | &nbsp;&nbsp;ADVISORY FEES |
| &nbsp;&nbsp;NET ASSETS: | &nbsp;&nbsp;HOLDINGS: | &nbsp;&nbsp;TURNOVER: | &nbsp;&nbsp;PAID BY FUND: |
| &nbsp;&nbsp;$21429091 | &nbsp;&nbsp;24 | &nbsp;&nbsp;8.15% | &nbsp;&nbsp;$106270 |

---

**<u>portfolio illustrations (% of total investments)</u>**

The following chart gives a breakdown of the Fund's portfolio of investments as of May 31, 2025. Sectors are based on Global Industry Classification Standard.

![](image_003.gif)

**<u>top ten holdings (% OF Net ASsets)</u>**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;1. | &nbsp;&nbsp; <br> Corcept Therapeutics, Inc. | &nbsp;&nbsp;18.91% |
| &nbsp;&nbsp;2. | &nbsp;&nbsp;NVIDIA Corp. | &nbsp;&nbsp;10.22% |
| &nbsp;&nbsp;3. | &nbsp;&nbsp;Apple, Inc. | &nbsp;&nbsp;10.21% |
| &nbsp;&nbsp;4. | &nbsp;&nbsp;Catalyst Pharmaceuticals, Inc. | &nbsp;&nbsp;9.45% |
| &nbsp;&nbsp;5. | &nbsp;&nbsp;NexGen Energy Ltd. | &nbsp;&nbsp;5.48% |
| &nbsp;&nbsp;6. | &nbsp;&nbsp;Stifel Financial Corp. | &nbsp;&nbsp;4.73% |
| &nbsp;&nbsp;7. | &nbsp;&nbsp;The Carlyle Group, Inc. | &nbsp;&nbsp;4.35% |
| &nbsp;&nbsp;8. | &nbsp;&nbsp;Symbotic, Inc. Class A | &nbsp;&nbsp;4.21% |
| &nbsp;&nbsp;9. | &nbsp;&nbsp;Aflac, Inc. | &nbsp;&nbsp;4.01% |
| &nbsp;&nbsp;10. | &nbsp;&nbsp;Philip Morris International, Inc. | &nbsp;&nbsp;2.92% |
|  | &nbsp;&nbsp;Total % of Net Assets | &nbsp;&nbsp;74.49% |

---

**<u>HOW HAS THE FUND CHANGED</u>**

The Fund has not had any material changes during the period ended May 31, 2025.

**<u>Householding</u>**

To reduce Fund expenses, only one copy of most shareholder documents may be mailed to shareholders with multiple accounts at the same address (Householding). If you would prefer that your Fund documents not be householded, please contact the Fund at 1-877-4-TANAKA, or contact your financial intermediary. Your instructions will typically be effective within 30 days of receipt by Fund or your financial intermediary.

For additional information about the Fund, including its prospectus, financial information, holdings and proxy voting information, visit https://tanaka.com/tanaka-growth-fund or contact the Fund at 1-877-4-TANAKA.

**Item 2. Code of Ethics.**

(a)&nbsp;&nbsp;&nbsp;&nbsp; As of the end of the period covered by this report, the registrant has adopted a code of ethics that applies to the registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party. A copy of registrant's code of ethics will be provided to any person who requests it, without charge. To receive a copy of the registrant's code of ethics, write to the Fund at Tanaka Funds, Inc., 60 East 42<sup>nd</sup> Street, Suite 4000, New York, NY 10165.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) For purposes of this item, "code of ethics" means written standards that are reasonably designed
to deter wrongdoing and to promote:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest
between personal and professional relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Full, fair, accurate, timely, and understandable disclosure in reports and documents that a registrant
files with, or submits to, the Commission and in other public communications made by the registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp; Compliance with applicable governmental laws, rules, and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) The prompt internal reporting of violations of the code to an appropriate person or persons identified
in the code; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;&nbsp;&nbsp;&nbsp; Accountability for adherence to the code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Amendments: During the period covered by the report, there have not been any amendments to the provisions
of the code of ethics.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Waivers: During the period covered by this report, the registrant has not granted any waivers, including
implicit waivers, from the provisions of the code of ethics.

**Item 3. Audit Committee Financial Expert.**

The registrant's board of directors has determined that Mr. David Fox is an audit committee financial expert. Mr. David Fox is independent for purposes of this Item 3. He has acquired his attributes through education and experience.

**Item 4. Principal Accountant Fees and Services.** Not applicable.

**Item 5. Audit Committee of Listed Companies.** Not applicable.

**Item 6. Schedule of Investments.**

Not applicable – schedule filed with Item 7.

**Item 7. Financial Statements and Financial Highlights for Open-End Management Companies.**

**TANAKA Growth Fund**

![A black and white logo AI-generated content may be incorrect.](image_001.jpg)

SEMI-ANNUAL FINANCIAL STATEMENTS

May 31, 2025

(Unaudited)

Fund Advisor:

Tanaka Capital Management, Inc.

60 East 42<sup>nd</sup> Street, Suite 4000

New York, NY 10165

Toll Free (877) 4TANAKA

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** |
| &nbsp;&nbsp;**Schedule of Investments** | &nbsp;&nbsp;**Schedule of Investments** | &nbsp;&nbsp;**Schedule of Investments** |
| &nbsp;&nbsp;**May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**May 31, 2025 (Unaudited)** |
| &nbsp;&nbsp;**<u>Shares</u>** |  | &nbsp;&nbsp;**<u>Value</u>** |
| &nbsp;&nbsp;**COMMON STOCKS - 96.97%** | &nbsp;&nbsp;**COMMON STOCKS - 96.97%** |  |
| &nbsp;&nbsp;**Accident & Health Insurance - 4.01%** | &nbsp;&nbsp;**Accident & Health Insurance - 4.01%** |  |
| &nbsp;&nbsp;8290 | &nbsp;&nbsp;Aflac, Inc. | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 858347 |
| &nbsp;&nbsp;**Beverages - 0.67%** | &nbsp;&nbsp;**Beverages - 0.67%** |  |
| &nbsp;&nbsp;1100 | &nbsp;&nbsp;PepsiCo, Inc. | &nbsp;&nbsp;144595 |
| &nbsp;&nbsp;**Biotech - 1.88%** | &nbsp;&nbsp;**Biotech - 1.88%** |  |
| &nbsp;&nbsp;190000 | &nbsp;&nbsp;Nuvation Bio, Inc. Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 402800 |
| &nbsp;&nbsp;**Cigarettes - 2.92%** | &nbsp;&nbsp;**Cigarettes - 2.92%** |  |
| &nbsp;&nbsp;3460 | &nbsp;&nbsp;Philip Morris International, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 624841 |
| &nbsp;&nbsp;**Electronic Computers - 10.20%** | &nbsp;&nbsp;**Electronic Computers - 10.20%** |  |
| &nbsp;&nbsp;10888 | &nbsp;&nbsp;Apple, Inc. | &nbsp;&nbsp;2186855 |
| &nbsp;&nbsp;**General Industrial Machinery & Equipment - 4.21%** | &nbsp;&nbsp;**General Industrial Machinery & Equipment - 4.21%** |  |
| &nbsp;&nbsp;31500 | &nbsp;&nbsp;Symbotic, Inc. Class A \* | &nbsp;&nbsp;903105 |
| &nbsp;&nbsp;**Investment Advice - 4.35%** | &nbsp;&nbsp;**Investment Advice - 4.35%** |  |
| &nbsp;&nbsp;20625 | &nbsp;&nbsp;The Carlyle Group, Inc. | &nbsp;&nbsp;932250 |
| &nbsp;&nbsp;**Measuring & Controlling Device - 2.25%** | &nbsp;&nbsp;**Measuring & Controlling Device - 2.25%** |  |
| &nbsp;&nbsp;5253 | &nbsp;&nbsp;Onto Innovation, Inc. \* | &nbsp;&nbsp;482961 |
| &nbsp;&nbsp;**Miscellaneous Metal Ores - 10.08%** | &nbsp;&nbsp;**Miscellaneous Metal Ores - 10.08%** |  |
| &nbsp;&nbsp;16500 | &nbsp;&nbsp;Aura Minerals, Inc. (British Virgin Islands) # | &nbsp;&nbsp;373970 |
| &nbsp;&nbsp;6500 | &nbsp;&nbsp;Cameco Corp. (Canada) # \* | &nbsp;&nbsp;380445 |
| &nbsp;&nbsp;190889 | &nbsp;&nbsp;NexGen Energy Ltd. (Canada) # \* | &nbsp;&nbsp;1173891 |
| &nbsp;&nbsp;39000 | &nbsp;&nbsp;Uranium Energy Corp. \* | &nbsp;&nbsp;231270 |
|  |  | &nbsp;&nbsp;2159576 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Pharmaceutical Preparations - 28.36%** | &nbsp;&nbsp;**Pharmaceutical Preparations - 28.36%** |  |
| &nbsp;&nbsp;81098 | &nbsp;&nbsp;Catalyst Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024206 |
| &nbsp;&nbsp;52255 | &nbsp;&nbsp;Corcept Therapeutics, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4052898 |
|  |  | &nbsp;&nbsp;6077104 |
| &nbsp;&nbsp;**Radio & TV Broadcasting & Communications Equipment - 2.25%** | &nbsp;&nbsp;**Radio & TV Broadcasting & Communications Equipment - 2.25%** |  |
| &nbsp;&nbsp;3323 | &nbsp;&nbsp;Qualcomm, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 482500 |
| &nbsp;&nbsp;**Retail-Catalog & Mail-Order Houses - 2.76%** | &nbsp;&nbsp;**Retail-Catalog & Mail-Order Houses - 2.76%** |  |
| &nbsp;&nbsp;2880 | &nbsp;&nbsp;Amazon.com, Inc. \* | &nbsp;&nbsp;590429 |
| &nbsp;&nbsp;**Security Brokers, Dealers & Flotation Companies - 4.73%** | &nbsp;&nbsp;**Security Brokers, Dealers & Flotation Companies - 4.73%** |  |
| &nbsp;&nbsp;10760 | &nbsp;&nbsp;Stifel Financial Corp. | &nbsp;&nbsp;1013807 |
| &nbsp;&nbsp;**Semiconductors & Related Devices - 13.05%** | &nbsp;&nbsp;**Semiconductors & Related Devices - 13.05%** |  |
| &nbsp;&nbsp;3870 | &nbsp;&nbsp;Applied Materials, Inc. | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 606622 |
| &nbsp;&nbsp;16200 | &nbsp;&nbsp;NVIDIA Corp. | &nbsp;&nbsp;2189106 |
|  |  | &nbsp;&nbsp;2795728 |
| &nbsp;&nbsp;**Services-Business Services - 1.53%** | &nbsp;&nbsp;**Services-Business Services - 1.53%** |  |
| &nbsp;&nbsp;560 | &nbsp;&nbsp;MasterCard, Inc. Class A | &nbsp;&nbsp;327936 |
| &nbsp;&nbsp;**Services-Computer Programming, Data - 2.30%** | &nbsp;&nbsp;**Services-Computer Programming, Data - 2.30%** |  |
| &nbsp;&nbsp;760 | &nbsp;&nbsp;Meta Platforms, Inc. Class A | &nbsp;&nbsp;492092 |
| &nbsp;&nbsp;**Special Industry Machinery - 1.42%** | &nbsp;&nbsp;**Special Industry Machinery - 1.42%** |  |
| &nbsp;&nbsp;1945 | &nbsp;&nbsp;Chart Industries, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 305093 |
| &nbsp;&nbsp;TOTAL FOR COMMON STOCKS (Cost $7,071,702) - 96.97% | &nbsp;&nbsp;TOTAL FOR COMMON STOCKS (Cost $7,071,702) - 96.97% | &nbsp;&nbsp; 20780019 |
| &nbsp;&nbsp;**EXCHANGE TRADED FUND - 1.92%** | &nbsp;&nbsp;**EXCHANGE TRADED FUND - 1.92%** |  |
| &nbsp;&nbsp;21000 | &nbsp;&nbsp;ProShares UltraPro Short S&P500 ETF | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411180 |
| &nbsp;&nbsp;TOTAL FOR EXCHANGE TRADED FUND (Cost $735,758) - 1.92% | &nbsp;&nbsp;TOTAL FOR EXCHANGE TRADED FUND (Cost $735,758) - 1.92% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 411180 |
| &nbsp;&nbsp;**SHORT-TERM INVESTMENTS - 1.23%** | &nbsp;&nbsp;**SHORT-TERM INVESTMENTS - 1.23%** |  |
| &nbsp;&nbsp;264678 | &nbsp;&nbsp;Huntington Conservative Deposit Account 4.16% \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 264678 |
| &nbsp;&nbsp;TOTAL FOR SHORT-TERM INVESTMENTS (Cost $264,678) - 1.23% | &nbsp;&nbsp;TOTAL FOR SHORT-TERM INVESTMENTS (Cost $264,678) - 1.23% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 264678 |
| &nbsp;&nbsp;TOTAL INVESTMENTS (Cost $8,072,138) - 100.12% | &nbsp;&nbsp;TOTAL INVESTMENTS (Cost $8,072,138) - 100.12% | &nbsp;&nbsp;21455877 |
| &nbsp;&nbsp;LIABILITIES LESS OTHER ASSETS, NET - (0.12)% | &nbsp;&nbsp;LIABILITIES LESS OTHER ASSETS, NET - (0.12)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (26786) |
| &nbsp;&nbsp;NET ASSETS - 100.00% | &nbsp;&nbsp;NET ASSETS - 100.00% | &nbsp;&nbsp;$21429091 |
| &nbsp;&nbsp;\* Non-income producing securities during the period. | &nbsp;&nbsp;\* Non-income producing securities during the period. |  |

---

---

| |
|:---|
| &nbsp;&nbsp;\*\* The Conservative Deposit Account ("CDA") is a short-term investment vehicle in which the Fund holds cash balances. The |
| &nbsp;&nbsp;CDA will bear interest at a variable rate that is determined based on conditions and may change daily and by any amount.The |
| &nbsp;&nbsp;coupon rate shown represents the yield at May 31, 2025. |
| &nbsp;&nbsp;# Total value for foreign common stock is $1,928,306, representing 9.00% of net assets. |
| &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. |

---

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**TANAKA Growth Fund** |  |
| &nbsp;&nbsp;**Statement of Assets and Liabilities** | &nbsp;&nbsp;**Statement of Assets and Liabilities** | &nbsp;&nbsp;**Statement of Assets and Liabilities** |
| &nbsp;&nbsp;**May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**May 31, 2025 (Unaudited)** |
| &nbsp;&nbsp;Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investments, at Value (Cost $8,072,138) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investments, at Value (Cost $8,072,138) | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 21455877 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivables: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivables: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends and Interest | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends and Interest | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8645 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid Expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid Expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21482093 |
| &nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to Advisor | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to Advisor | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder Redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder Redemptions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7962 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors' Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors' Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2366 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit Fees |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7237 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Custody Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Custody Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2011 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distribution (12b-1) Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distribution (12b-1) Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3716 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Printing and Mailing Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Printing and Mailing Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfer Agent and Fund Accounting Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfer Agent and Fund Accounting Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7481 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1709 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Liabilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 53002 |
| &nbsp;&nbsp;Net Assets |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 21429091 |
| &nbsp;&nbsp;Net Assets Consist of: | &nbsp;&nbsp;Net Assets Consist of: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-In Capital | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-In Capital | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7373747 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributable Earnings | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributable Earnings | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14055344 |
| &nbsp;&nbsp;Net Assets, for 453,795 Shares Outstanding | &nbsp;&nbsp;Net Assets, for 453,795 Shares Outstanding | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 21429091 |
| &nbsp;&nbsp;Net Asset Value and Offering Price Per Share | &nbsp;&nbsp;Net Asset Value and Offering Price Per Share | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47.22 |
| &nbsp;&nbsp;Minimum Redemption Price Per Share ($47.22\*0.98) (Note 6) (a) | &nbsp;&nbsp;Minimum Redemption Price Per Share ($47.22\*0.98) (Note 6) (a) | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46.28 |
| &nbsp;&nbsp;(a) A minimum redemption fee of 2% is imposed in the event of certain redemption transactions occuring | &nbsp;&nbsp;(a) A minimum redemption fee of 2% is imposed in the event of certain redemption transactions occuring | &nbsp;&nbsp;(a) A minimum redemption fee of 2% is imposed in the event of certain redemption transactions occuring |
| &nbsp;&nbsp;within 5 days of purchase. | &nbsp;&nbsp;within 5 days of purchase. |  |

---

The accompanying notes are an integral part of these financial statements.

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**TANAKA Growth Fund** |  |
| &nbsp;&nbsp;**Statement of Operations** | &nbsp;&nbsp;**Statement of Operations** | &nbsp;&nbsp;**Statement of Operations** |
| &nbsp;&nbsp;**For the six months ended May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**For the six months ended May 31, 2025 (Unaudited)** | &nbsp;&nbsp;**For the six months ended May 31, 2025 (Unaudited)** |
| &nbsp;&nbsp;Investment Income: | &nbsp;&nbsp;Investment Income: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 77724 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8926 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Investment Income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Investment Income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86650 |
| &nbsp;&nbsp;Expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Advisory |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 106270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Distribution (12b-1) Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Distribution (12b-1) Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26568 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer Agent and Fund Accounting | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer Agent and Fund Accounting | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administrative | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administrative | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10627 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Audit |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Registration | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Registration | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Legal |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7968 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Printing and Mailing | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Printing and Mailing | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7784 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors' Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors' Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insurance |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5021 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miscellaneous | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Miscellaneous | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4271 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Custody Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Custody Fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3878 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 216629 |
| &nbsp;&nbsp;Net Investment Loss | &nbsp;&nbsp;Net Investment Loss | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (129979) |
| &nbsp;&nbsp;Realized and Unrealized Gain on Investments and Foreign Currency Transactions: | &nbsp;&nbsp;Realized and Unrealized Gain on Investments and Foreign Currency Transactions: |  |
| &nbsp;&nbsp; Net Realized Gain on Investments and Foreign Currency Transactions | &nbsp;&nbsp; Net Realized Gain on Investments and Foreign Currency Transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1295205 |
| &nbsp;&nbsp; Net Change in Unrealized Depreciation on Investments and Foreign Currency Transactions | &nbsp;&nbsp; Net Change in Unrealized Depreciation on Investments and Foreign Currency Transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2081465) |
| &nbsp;&nbsp;Realized and Unrealized Loss on Investments and Foreign Currency Transactions: | &nbsp;&nbsp;Realized and Unrealized Loss on Investments and Foreign Currency Transactions: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (786260) |
| &nbsp;&nbsp;Net Decrease in Net Assets Resulting from Operations | &nbsp;&nbsp;Net Decrease in Net Assets Resulting from Operations | &nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; (916239) |
| &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. | &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. |  |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** |
| &nbsp;&nbsp;**Statements of Changes in Net Assets** | &nbsp;&nbsp;**Statements of Changes in Net Assets** | &nbsp;&nbsp;**Statements of Changes in Net Assets** |
|  | &nbsp;&nbsp;(Unaudited) |  |
|  | &nbsp;&nbsp;Six Months |  |
|  | &nbsp;&nbsp;Ended | &nbsp;&nbsp;Year Ended |
|  | &nbsp;&nbsp;5/31/2025 | &nbsp;&nbsp;11/30/2024 |
| &nbsp;&nbsp;Increase (Decrease) in Net Assets From Operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Investment Loss | &nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; (129979) | &nbsp;&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp; (265843) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Realized Gain on Investments and Foreign Currency Transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1295205 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3178916 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Change in Unrealized Appreciation (Depreciation) on Investments and Foreign Currency Transactions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2081465) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3057464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Increase (Decrease) in Net Assets Resulting from Operations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (916239) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5970537 |
| &nbsp;&nbsp;Total Distributions Paid to Shareholders |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realized Gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1390141) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Return of Capital | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Distributions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1390141) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - |
| &nbsp;&nbsp;Capital Share Transactions (Note 6) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;463623 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3529603) |
| &nbsp;&nbsp;Total Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1842757) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2440934 |
| &nbsp;&nbsp;Net Assets: |  |  |
| &nbsp;&nbsp;Beginning of Period/Year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23271848 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20830914 |
| &nbsp;&nbsp;End of Period/Year | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 21429091 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 23271848 |
| &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** | &nbsp;&nbsp;**TANAKA Growth Fund** |
| &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** | &nbsp;&nbsp;**Financial Highlights** |
| &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** | &nbsp;&nbsp;**Selected data for a share outstanding throughout each period/year.** |
|  | &nbsp;&nbsp;(Unaudited) |  |  |  |  |  |  |  |
|  | &nbsp;&nbsp;Six Months |  |  |  |  |  |  |  |
|  | &nbsp;&nbsp;Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended | &nbsp;&nbsp;Years Ended |
|  | &nbsp;&nbsp;5/31/2025 | &nbsp;&nbsp;11/30/2024 | &nbsp;&nbsp;11/30/2023 | &nbsp;&nbsp;11/30/2022 |  | &nbsp;&nbsp;11/30/2021 |  | &nbsp;&nbsp;11/30/2020 |
| &nbsp;&nbsp;Net Asset Value, at Beginning of Period/Year | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 52.37 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 39.51 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 29.65 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 40.09 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 24.71 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 19.94 |
| &nbsp;&nbsp;Income From Investment Operations: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp; Net Investment Loss \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.28) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.56) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.35) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.37) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.64) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.29) |
| &nbsp;&nbsp; Net Gain (Loss) on Securities (Realized and Unrealized) \*\*\*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.71) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.42 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.24 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7.42) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.02 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total from Investment Operations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.99) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12.86 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9.89 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7.79) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15.38 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.77 |
| &nbsp;&nbsp;Distributions: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp; Realized Gains | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3.16) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.03) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2.65) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| &nbsp;&nbsp; Return of Capital | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp; † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total from Distributions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3.16) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.03) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2.65) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| &nbsp;&nbsp; Redemption Fees \*\*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp; † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| &nbsp;&nbsp;Net Asset Value, at End of Period/Year | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47.22 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 52.37 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 39.51 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 29.65 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 40.09 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 24.71 |
| &nbsp;&nbsp;Total Return \*\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3.76)% &nbsp;&nbsp;(b) | &nbsp;&nbsp;32.55% | &nbsp;&nbsp;33.41% | &nbsp;&nbsp; (20.58)% |  | &nbsp;&nbsp;62.24% |  | &nbsp;&nbsp;23.92% |
| &nbsp;&nbsp;Ratios/Supplemental Data: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp; Net Assets at End of Period/Year (Thousands) | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 21429 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 23272 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 20831 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 15465 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 22638 |  | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 11082 |
| &nbsp;&nbsp; Before Waivers or Recoupments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ratio of Expenses to Average Net Assets | &nbsp;&nbsp;2.04% &nbsp;&nbsp;(a) | &nbsp;&nbsp;1.99% | &nbsp;&nbsp;2.15% | &nbsp;&nbsp;2.14% |  | &nbsp;&nbsp;1.98% |  | &nbsp;&nbsp;2.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ratio of Net Investment Loss to Average Net Assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.22)% &nbsp;&nbsp;(a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.26)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.08)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.19)% |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.37)% |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.69)% |
| &nbsp;&nbsp; After Waivers or Recoupments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ratio of Expenses to Average Net Assets | &nbsp;&nbsp;2.04% &nbsp;&nbsp;(a) | &nbsp;&nbsp;1.99% | &nbsp;&nbsp;2.15% | &nbsp;&nbsp;2.14% |  | &nbsp;&nbsp;2.19% |  | &nbsp;&nbsp;2.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ratio of Net Investment Loss to Average Net Assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.22)% &nbsp;&nbsp;(a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.26)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.08)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.19)% |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.58)% |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1.44)% |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; Portfolio Turnover | &nbsp;&nbsp;8.15% | &nbsp;&nbsp;(b) | &nbsp;&nbsp;15.04% | &nbsp;&nbsp;8.60% | &nbsp;&nbsp;7.65% | &nbsp;&nbsp;37.50% | &nbsp;&nbsp;15.08% |
| &nbsp;&nbsp;\* Per share net investment loss has been determined on the basis of average shares outstanding during the year. | &nbsp;&nbsp;\* Per share net investment loss has been determined on the basis of average shares outstanding during the year. | &nbsp;&nbsp;\* Per share net investment loss has been determined on the basis of average shares outstanding during the year. | &nbsp;&nbsp;\* Per share net investment loss has been determined on the basis of average shares outstanding during the year. | &nbsp;&nbsp;\* Per share net investment loss has been determined on the basis of average shares outstanding during the year. |  |  |  |
| &nbsp;&nbsp;\*\* Assumes reinvestment of dividends, if any. |  |  |  |  |  |  |  |
| &nbsp;&nbsp;\*\*\* The Fund will impose a 2.00% redemption fee on shares redeemed within 5 days of purchase. | &nbsp;&nbsp;\*\*\* The Fund will impose a 2.00% redemption fee on shares redeemed within 5 days of purchase. | &nbsp;&nbsp;\*\*\* The Fund will impose a 2.00% redemption fee on shares redeemed within 5 days of purchase. | &nbsp;&nbsp;\*\*\* The Fund will impose a 2.00% redemption fee on shares redeemed within 5 days of purchase. |  |  |  |  |
| &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the | &nbsp;&nbsp;\*\*\*\* Realized and unrealized gains per share are balancing amounts necessary to reconcile the change in net asset value per share for the |  |
| &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. | &nbsp;&nbsp;period, and may not accord with the aggregate gains and losses in the Statement of Operations due to share transactions for the period. |  |
| &nbsp;&nbsp;(a) Annualized. |  |  |  |  |  |  |  |
| &nbsp;&nbsp;(b) Not Annualized. |  |  |  |  |  |  |  |
| &nbsp;&nbsp;† Amount less than $0.005 per share. |  |  |  |  |  |  |  |
| &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. | &nbsp;&nbsp;The accompanying notes are an integral part of these financial statements. |  |  |  |  |  |  |

---

**TANAKA Growth Fund**

Notes to Financial Statements

May 31, 2025 (Unaudited)

**NOTE 1. ORGANIZATION**

The TANAKA Growth Fund (the "Fund") was organized as a series of TANAKA Funds, Inc., a Maryland corporation (the "Company") on November 5, 1997; the Fund commenced operations on December 30, 1998. The Fund is registered under the Investment Company Act of 1940, as amended, as a non-diversified open-end management investment company. The Fund's investment objective is to provide growth of capital. The Investment Advisor of the Fund is Tanaka Capital Management, Inc. (the "Advisor").

**NON-DIVERSIFICATION RISK:** As a non-diversified fund, the Fund may invest larger positions in small number of companies of its total assets. The Fund's performance may be more sensitive to any single economic, business, political or regulatory occurrence than the value of shares of a diversified investment company. The Fund's performance may be affected disproportionately by the performance of relatively few stocks. In addition, the volatility of the Fund may be greater than the overall volatility of the market.

**NOTE 2. SIGNIFICANT ACCOUNTING POLICIES**

The following is a summary of the significant accounting policies followed by the Fund in the preparation of its financial statements. The Fund is an investment company that follows the accounting and reporting guidance of Accounting Standards Codification Topic 946 applicable to investment companies.

*Securities Valuations* - All investments in securities are recorded at their estimated fair value, as described in Note 3.

*Federal Income Taxes* – The Fund makes no provision for federal income or excise tax. The Fund intends to qualify each year as "regulated investment companies" ("RIC") under subchapter M of the Internal Revenue Code of 1986, as amended, by complying with the requirements applicable to RICs and by distributing substantially all of its taxable income. The Fund also intends to distribute sufficient net investment income and net capital gains, if any, so that it will not be subject to excise tax on undistributed income and gains. If the required amount of net investment income or gains is not distributed, the Fund could incur a tax expense. Therefore, no federal income tax or excise provision is required.

The Fund recognizes the tax benefits of uncertain tax positions only when the position is more likely than not to be sustained, assuming examination by tax authorities. Management has analyzed the Fund's tax positions and concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years (2021-2023) or expected to be taken in the Fund's 2024 tax returns. The Fund identifies its major tax jurisdiction as U.S. Federal, however the Fund is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

The Fund recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the Statement of Operations. During the six months ended May 31, 2025, the Fund did not incur any interest or penalties.

 

*Security Transactions and Related Income* - The Fund follows industry practice and records security transactions on the trade date. The specific identification method is used for determining gains or losses for financial statements and income tax purposes. Dividend income less foreign taxes withheld is recorded on the ex-dividend date and interest income is recorded on an accrual basis. Discounts and premiums on securities purchased are amortized over the life of the respective securities. Withholding taxes on foreign dividends have been provided for in accordance with the Fund's understanding of the applicable country's tax rules and rates.

 

*Dividends and Distributions* - The Fund intends to distribute substantially all of its net investment income as dividends to its shareholders on at least an annual basis. The Fund intends to distribute its net realized long-term capital gains and its net realized short-term capital gains at least once a year. Distributions to shareholders which are determined in accordance with income tax regulations and are recorded on the ex-dividend date. The treatment for financial reporting purposes of distributions made to shareholders during the year from net investment income or net realized capital gains may differ from its ultimate treatment for federal income tax purposes. These differences are caused by differences in the timing of the recognition of certain components of income, expense or realized capital gain for federal income tax purposes. Where such differences are permanent in nature, they are reclassified in the components of the net assets based on their ultimate characterization for federal income tax purposes. Any such reclassifications will have no effect on net assets, results of operations or net asset values per share of the Fund.

*Foreign Currency* - Investment securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollar amounts at the date of valuation. Purchases and sales of investment securities and income and expense items denominated in foreign currencies are translated into U.S. dollar amounts on the respective dates of such transactions. The Fund does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations are included with the net realized and unrealized gain or loss from investments. Reported net realized foreign exchange gains or losses arise from sales of foreign currencies, currency gains or losses realized between the trade and settlement dates on securities transactions, and the difference between the amounts of dividends, interest, and foreign withholding taxes recorded on a Fund's books and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses arise from changes in the fair values of assets and liabilities, other than investments in securities at fiscal period end, resulting from changes in exchange rates.

*Use of Estimates* - The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.

*Cash and cash equivalents* – The Fund considers all highly liquid debt instruments having original maturities of three months or less at the date of purchase to be cash equivalents. The Fund may, during the ordinary course of business, maintain account balances with banks in excess of federally insured limits. The Fund has not experienced losses on these accounts, and management believes that the Fund is not exposed to significant risks on such accounts.

**NOTE 3. SECURITIES VALUATIONS** 

***Processes and Structure***

 ****

The Fund's Board of Directors (the "Board") has adopted guidelines for valuing securities including in circumstances in which market quotes are not readily available and has designated the Advisor as the valuation designee in accordance with Rule 2a-5 of the Investment Company Act of 1940.

 ****

*Fair Value Pricing –* Under certain circumstances, the Advisor will use its best efforts to arrive at the fair value of a security held by the Fund under all reasonably ascertainable facts and circumstances. The Advisor must prepare a report for the Board not less than quarterly containing a complete listing of any securities for which fair value pricing was employed and detailing the specific reasons for such fair value pricing. The Fund has adopted written policies and procedures to guide the Advisor with respect to the circumstances under which, and the methods to be used, in fair valuing securities.

The Fund invests the majority of its assets in frequently traded exchange listed securities of domestic issuers with relatively liquid markets and calculates its NAV as of the time those exchanges close. However, the Fund may invest in securities on foreign exchanges or in illiquid or restricted securities. Accordingly, there may be circumstances under which the Fund would hold a security that would need to be fair value priced. Examples of when it would be likely that the Fund security would require fair value pricing include but are not limited to: if the exchange on which a portfolio security trades were to close early; if trading in a particular security were to be halted on an exchange and did not resume trading prior to calculation of NAV; if a significant event that materially affected the value of a security were to occur after the securities' exchange had closed but before the Fund's NAV had been calculated; and if a security that had a significant exposure to foreign operations was subject to a material event or occurrence in a foreign jurisdiction in which the company had significant operations.

***Hierarchy of Fair Value Inputs***

The Fund utilizes various methods to measure the fair value of most of its investments on a recurring basis. GAAP establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs are as follows:

· *Level 1.* Unadjusted quoted prices in active markets for identical
assets or liabilities that the Fund has the ability to access.

· *Level 2.* Observable inputs other than quoted prices included in Level
1 that are observable for the asset or liability either directly or indirectly. These inputs may include quoted prices for the identical
instrument on an inactive market, prices for

similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

· *Level 3.* Unobservable inputs for the asset or liability to the extent
that relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions that a market participant
would use in valuing the asset or liability at the measurement date, and that would be based on the best information available.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.

The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

***Fair Value Measurements***

A description of the valuation techniques applied to the Fund's major categories of assets and liabilities measured at fair value on a recurring basis follows.

*Equity securities (Domestic and Foreign common stock) -* Securities traded on a national securities exchange (or reported on the NASDAQ national market) are stated at the last reported sales price on the day of valuation. To the extent these securities are actively traded, and valuation adjustments are not applied, they are categorized in Level 1 of the fair value hierarchy. Certain foreign securities may be fair valued using a pricing service that considers the correlation of the trading patterns of the foreign security to the intraday trading in the U.S. markets for investments such as American Depositary Receipts, financial futures, Exchange Traded Funds, and the movement of the certain indexes of securities based on a statistical analysis of the historical relationship, and are categorized in Level 2.

*Fixed income securities (convertible bonds)* - The fair value of fixed income securities is estimated using various techniques, which may consider recently executed transactions in securities of the issuer or comparable issuers, market price quotations (when observable), bond spreads, fundamental data relating to the issuer, and credit default swap spreads adjusted for any basis difference between cash and derivative instruments. Although most fixed income securities are categorized in level 2 of the fair value hierarchy, in instances when lower relative weight is placed on transaction prices, quotations, or similar observable inputs, they are categorized in level 3.

*Short term investments -* Short term investments are valued using amortized cost, which approximates fair value. These securities will be categorized in Level 1 of the fair value hierarchy. Money market funds are valued at their net asset value of $1 per share and are categorized in Level 1.

The following table summarizes the inputs used to value the Fund's assets measured at fair value as of May 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Financial Instruments—Assets** | &nbsp;&nbsp;**Financial Instruments—Assets** | &nbsp;&nbsp;**Financial Instruments—Assets** | &nbsp;&nbsp;**Financial Instruments—Assets** |
| &nbsp;&nbsp;***Categories*** | &nbsp;&nbsp;***Level 1*** | &nbsp;&nbsp;***Level 2*** | &nbsp;&nbsp;***Level 3*** | &nbsp;&nbsp;***Fair Value*** |
| &nbsp;&nbsp;Common Stocks \* | &nbsp;&nbsp;$20780019 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;$20780019 |
| &nbsp;&nbsp;Exchange Traded Fund | &nbsp;&nbsp;411180 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;411180 |
| &nbsp;&nbsp;Short-Term Investments | &nbsp;&nbsp;264678 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;264678 |
|  | &nbsp;&nbsp;$21455877 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;$21455877 |

---

\*Industry classifications for these categories are detailed in the Schedule of Investments.

**NOTE 4. FEES AND OTHER TRANSACTIONS WITH AFFILIATES**

The Fund retains the Advisor to manage the Fund's investments and act as Administrator to the Fund. The Advisor was organized as a Delaware corporation in 1986. Graham Y. Tanaka, portfolio manager and President of the Advisor, and Benjamin Bratt, portfolio manager and Treasurer, are primarily responsible for the day-to-day management of the Fund's portfolio. Certain officers of the Advisor serve as director and officers of the Fund.

Under the terms of an Investment Advisory Agreement, (the "Advisory Agreement"), the Advisor manages the Fund's investments subject to approval by the Board. As compensation for its management services, the Fund is obligated to pay the Advisor a fee computed and accrued daily and paid monthly at an annual rate of 1.00% of the average daily net assets of the Fund. For the six months ended May 31, 2025, the Advisor earned a fee of $106,270 from the Fund. At May 31, 2025, the Fund owed the Advisor $17,367 for management fees.

Pursuant to a written expense limitation agreement, the Fund's Adviser has agreed to waive or limit its fees and assume other expenses of the Fund (excluding interest, taxes, brokerage commissions and other expenditures capitalized in accordance with generally accepted accounting principles or other extraordinary expenses), so that the Fund's ratio of total annual operating expenses is limited to 2.45% for Class R shares. The expense limitation agreement is effective on an annual basis and may be terminated only by the Board of Trustees by providing 90 days notice, or if the Adviser ceases to serve as adviser to the Fund. The Adviser is entitled to reimbursement of fees waived or expenses assumed subject to the limitations that (i) the reimbursements is made for fees waived or expenses incurred not more than three years prior to the date of the reimbursement and (ii) the reimbursement may not be made if it would cause the Fund's annual expense limitation to be exceeded for Class R Shares. Further, any recoupments will be subject to any lower expenses limitations that have been later implemented by the Board. As of the six months ended May 31, 2025, there are no previously reimbursed fees available for recoupment.

Under the terms of the Administrative Agreement, the Advisor will provide administrative services which are necessary for the day-to-day operations of the Fund. As compensation for the administrative services, the Fund is obligated to pay the Advisor a fee computed and accrued daily and paid monthly at an annual rate of 0.10% of the first $50 million in average daily net assets of the Fund. For the six months ended May 31, 2025, the Advisor earned a fee of $10,627 from the Fund under the Administrative Agreement. At May 31, 2025, the Fund owed the Advisor $1,773 for administrative fees.

The Fund has adopted a plan pursuant to Rule 12b-1 under the Investment Company Act of 1940 for each class of shares authorized (each such plan, a "Distribution Plan") as amended and approved on December 14, 2020. The Fund is obligated to pay a fee computed and accrued daily at an annual rate not greater than 0.25% of the average daily net assets. The 12b-1 fees are paid to brokers, dealers and other financial institutions, including the investment adviser to the "Fund", (collectively, the "Service Organizations") for services in connection with sales of shares of the Fund. Total fees incurred under the Distribution Plan for the six months ended May 31, 2025, were $26,568. For the six months ended May 31, 2025, the Advisor received 12b-1 fees of $16,315 that were used by the Advisor to cover allowable expenses under the Distribution Plan.

**NOTE 5. INVESTMENTS**

For the six months ended May 31, 2025, purchases and sales of investment securities, excluding short-term investments were as follows:

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;**<u>Amount</u>** |
| &nbsp;&nbsp;Purchases | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;1747740 |
| &nbsp;&nbsp;Sales | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;3033427 |

---

**NOTE 6. CAPITAL SHARES**

The Company is authorized to issue up to 250,000,000 shares of common stock, par value $0.01 per share, of which it currently has allocated 150,000,000 shares to the Fund. Capital share transactions for the six months ended May 31, 2025 and year ended November 30, 2024, respectively, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;Six Months Ended 5/31/25 | &nbsp;&nbsp;Six Months Ended 5/31/25 | &nbsp;&nbsp;Year Ended 11/30/24 | &nbsp;&nbsp;Year Ended 11/30/24 |
|  | &nbsp;&nbsp;Shares | &nbsp;&nbsp;$ Amount | &nbsp;&nbsp;Shares | &nbsp;&nbsp;$ Amount |
| &nbsp;&nbsp;Shares sold | &nbsp;&nbsp;11450 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 517256 | &nbsp;&nbsp;38697 | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;1623391 |
| &nbsp;&nbsp;Shares reinvested | &nbsp;&nbsp;28906 | &nbsp;&nbsp;1354267 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Shares redeemed | &nbsp;&nbsp; (30955) | &nbsp;&nbsp; (1407900) | &nbsp;&nbsp; (121499) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5152994) |
| &nbsp;&nbsp;Net increase (decrease) | &nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp; 9401</u> | &nbsp;&nbsp;<u>$&nbsp;&nbsp;&nbsp;&nbsp; 463623</u> | &nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;(82802)</u> | &nbsp;&nbsp;<u>$(3529603)</u> |

---

For the six months ended May 31, 2025, the shares redeemed amounts include account servicing fees of $1,236 which were used to offset Transfer Agent fees on the Statement of Operations.

Shareholders will be subject to a Redemption Fee on redemptions and exchanges equal to 2.00% of the net asset value of Fund shares redeemed within 5 days after their purchase. For the six months ended May 31, 2025 and year ended November 30, 2024, no redemption fees were collected from shareholder transactions.

**NOTE 7. TAX MATTERS**

As of November 30, 2024, unrealized appreciation (depreciation) and cost of investment securities on a tax basis, were as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;Gross unrealized appreciation on investment securities | &nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;15490959 |
| &nbsp;&nbsp;Gross unrealized depreciation on investment securities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(25755) |
| &nbsp;&nbsp;Net unrealized appreciation on investment securities | &nbsp;&nbsp;<u>$&nbsp;&nbsp;&nbsp;&nbsp;15465204</u> |
| &nbsp;&nbsp;Tax Cost of investment securities \* | &nbsp;&nbsp;<u>$&nbsp;&nbsp;&nbsp;&nbsp; 7923206</u> |

---

\* Includes short-term investment.

The Fund's distributable earnings on a tax basis are determined only at the end of each fiscal year. As of November 30, 2024, the Fund's most recent fiscal year-end, the components of distributable earnings on a tax basis were as follows:

---

| | |
|:---|:---|
| Unrealized Appreciation | $15465204 |
| Ordinary Late Year Losses | (240994) |
| Undistributed Capital Gains | &nbsp;&nbsp;&nbsp;&nbsp;1137514 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; Total Distributable Earnings, Net | $<u>16361724</u> |

---

Under current tax law, net capital losses realized after October 31 and net ordinary losses incurred after December 31 may be deferred and treated as occurring on the first day of the following fiscal year. The Fund's carryforward losses, post-October losses and late year losses are determined only at the end of each fiscal year. As of November 30, 2024, the Fund elected to defer ordinary late year losses as indicated in the chart below.

---

| | |
|:---|:---|
| &nbsp;&nbsp;Ordinary Late Year Losses Deferred | &nbsp;&nbsp;$240994 |

---

As of November 30, 2024, the Fund recorded permanent book/tax differences of $63,107 from distributable earnings (a decrease to distributable earnings) to paid-in-capital (an increase to paid-in-capital) due to net operating losses and the utilization of earnings and profits distributed to shareholders on redemption of shares.

For tax purposes, net realized capital losses may be carried over to offset future capital gains, if any. Funds are permitted to carry forward capital losses for an indefinite period, and such losses will retain their character as either short-term or long-term capital losses. As of November 30, 2024, the Fund did not have any capital loss carryforwards. During the fiscal year, the Fund utilized $1,777,065 of capital loss carry forwards to offset current year net realized gains.

No distributions were paid by the Fund for the year ended November 30, 2024.

For the six months ended May 31, 2025, there was a long-term capital gain distribution of $1,390,145 paid.

**NOTE 8. INDEMNIFICATIONS**

In the normal course of business, the Fund enters into contracts that contain general indemnification to other parties. The Fund's maximum exposure under these contracts is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. The Fund expects the risk of loss to be remote.

**NOTE 9. SECTOR RISK**

If the Fund's portfolio is overweighted in a certain industry sector, any negative development affecting that sector will have a greater impact on the Fund than a fund that is not overweighted in that sector. For example, to the extent the Fund is overweighted in the technology sector it will be affected by developments affecting the applicable sector. The sector is subject to changing government regulations that may limit profits and restrict services offered. Companies in this sector also may be significantly affected by intense competition. In addition, technology products may be subject to rapid obsolescence.

**NOTE 10. MARKET RISK**

Overall market risks may also affect the value of the Fund. Factors such as domestic economic growth and market conditions, interest rate levels and political events affect the securities markets. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issue, recessions and depressions, or other events could have a significant impact on the Fund and its investments and may impair market liquidity, thereby increasing liquidity risk. The Fund could lose money over short periods due to short-term market movements and over longer periods during more prolonged market downturns. During a general market downturn, multiple asset classes may be negatively affected. Changes in market conditions and interest rates can have the same impact on all types of securities and instruments.

**NOTE 11. SUBSEQUENT EVENTS**

Management has evaluated the impact of all subsequent events on the Fund through the issuance of these financial statements and has noted no further events requiring disclosure or adjustment.

**TANAKA Growth Fund**

Additional Information

May 31, 2025 (Unaudited)

The Fund's Statement of Additional Information (SAI) includes additional information about the Directors and Officers and is available, without charge, upon request. You may call toll-free 1-877-4TANAKA to request a copy of the SAI or to make shareholder inquiries.

**PROXY VOTING AND QUARTERLY PORTFOLIO SCHEDULE (UNAUDITED)**

A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities and information regarding how the Fund voted proxies during the most recent 12 month period ended June 30, are available without charge upon request (1) by calling the Fund at 1-877-4TANAKA and (2) from Fund documents filed with the Securities and Exchange Commission ("SEC") on the SEC's website at www.sec.gov.

The Fund files a complete schedule of investments with the SEC for the first and third quarter of each fiscal year on Form N-PORT. The Fund's first and third fiscal quarters end on February 28 and August 31. The Fund's Forms N-PORT are available on the SEC's website at www.sec.gov, or they may be reviewed and copied at the SEC's Public Reference Room in Washington, DC (call 1-800-732-0330 for information on the operation of the Public Reference Room). You may also obtain copies by calling the Fund at 1-877-4TANAKA.

This report is intended only for the information of shareholders or those who have received the Fund's prospectus which contains information about the Fund's management fee and expenses. Please read the prospectus carefully before investing.

The Fund's Statement of Additional Information includes additional information about the Fund and is available upon request at no charge by calling the Fund.

**Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.** Not applicable.

**Item 9. Proxy Disclosures for Open-End Management Investment Companies.** Not applicable.

**Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.** The information is included as part of the material filed under Item 7 of this Form.

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract**. The information is included as part of the material filed under Item 7 of this Form.

**Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Funds.** Not applicable.

**Item 13. Portfolio Managers of Closed-End Funds.** Not applicable.

**Item 14. Purchases of Equity Securities by Closed-End Funds.** Not applicable.

**Item 15.** **Submission of Matters to a Vote of Security Holders.**

The registrant has not adopted procedures by which shareholders may recommend nominees to the registrant's board of directors.

**Item 16. Controls and Procedures.**

(a) &nbsp;&nbsp;&nbsp;&nbsp; The Principal Executive and Financial Officers concluded that the Registrant's Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing of this report.

(b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting.

**Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.** Not applicable.

**Item 18. Recovery of Erroneously Awarded Compensation.**

(a) Not applicable.

(b) Not applicable.

**Item 19. Exhibits.**

(a)(1) EX-99.CODE ETH. Not applicable.

(a)(2) EX-99.CERT. Filed herewith.

(a)(3) Any written solicitation to purchase securities under Rule 23c-1 under the Act (17 CFR 270.23c-1) sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons. Not applicable.

(b)&nbsp;&nbsp;&nbsp;&nbsp; EX-99.906CERT. Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

<u>TANAKA Funds, Inc.</u>

<u>By &nbsp;&nbsp;&nbsp;&nbsp; /s/ Graham Tanaka</u>

\*

&nbsp;&nbsp;&nbsp;&nbsp; Graham Tanaka, President

<u>Date &nbsp;&nbsp;&nbsp;&nbsp;July 31, 2025</u>

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

<u>By &nbsp;&nbsp;&nbsp;&nbsp;/s/ Graham Tanaka</u>

\*

&nbsp;&nbsp;&nbsp;&nbsp; Graham Tanaka, President

<u>Date July 31, 2025</u>

<u>By /s/ Benjamin Bratt</u>

\*

&nbsp;&nbsp;&nbsp;&nbsp; Benjamin Bratt, Chief Financial Officer

<u>Date July 31, 2025</u>

\* Print the name and title of each signing officer under his or her signature.

## Exhibit 99.906

EX-99.906CERT

**CERTIFICATION**

<u>Graham Tanaka</u>, President, and <u>Benjamin Bratt</u>, Chief Financial Officer of TANAKA Funds Inc., (the "Registrant"), each certify to the best of his or her knowledge that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Registrant's periodic report on Form N-CSR for the period ended May 31, 2025 (the "Form N-CSR") fully complies with the requirements of Sections 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

President

Chief Financial Officer

TANAKA Funds, Inc. Trust

TANAKA Funds, Inc. Trust

/s/<u>Graham Tanaka</u>

/s/<u>Benjamin Bratt</u>

Graham Tanaka

Benjamin Bratt

Date: <u>July 31, 2025</u>

Date: <u>July 31, 2025</u>

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to TANAKA Funds, Inc. Trust and will be retained by TANAKA Funds, Inc. Trust and furnished to the Securities and Exchange Commission (the "Commission") or its staff upon request.

This certification is being furnished to the Commission solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Form N-CSR filed with the Commission.

## Ex-99.Cert

I, Graham Tanaka, certify that:

1. I have reviewed this report on Form N-CSR of TANAKA Funds, Inc. ;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: <u>July 31, 2025</u>

<u>/s/ Graham Tanaka</u>

Graham Tanaka

President

I, Benjamin Bratt, certify that:

1. I have reviewed this report on Form N-CSR of TANAKA Funds, Inc. ;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: <u>July 31, 2025</u>

<u>/s/ Benjamin Bratt</u>

Benjamin Bratt

Chief Financial Officer

<br>